258 related articles for article (PubMed ID: 17428181)
1. ChREBP, a transcriptional regulator of glucose and lipid metabolism.
Postic C; Dentin R; Denechaud PD; Girard J
Annu Rev Nutr; 2007; 27():179-92. PubMed ID: 17428181
[TBL] [Abstract][Full Text] [Related]
2. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
3. Role of ChREBP in hepatic steatosis and insulin resistance.
Denechaud PD; Dentin R; Girard J; Postic C
FEBS Lett; 2008 Jan; 582(1):68-73. PubMed ID: 17716660
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice.
Iizuka K; Miller B; Uyeda K
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E358-64. PubMed ID: 16705063
[TBL] [Abstract][Full Text] [Related]
5. Cross-regulation of hepatic glucose metabolism via ChREBP and nuclear receptors.
Poupeau A; Postic C
Biochim Biophys Acta; 2011 Aug; 1812(8):995-1006. PubMed ID: 21453770
[TBL] [Abstract][Full Text] [Related]
6. Dietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice.
Jois T; Howard V; Youngs K; Cowley MA; Sleeman MW
PLoS One; 2016; 11(12):e0168797. PubMed ID: 27992582
[TBL] [Abstract][Full Text] [Related]
7. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].
Robichon C; Girard J; Postic C
Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580
[TBL] [Abstract][Full Text] [Related]
8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis.
Uyeda K; Repa JJ
Cell Metab; 2006 Aug; 4(2):107-10. PubMed ID: 16890538
[TBL] [Abstract][Full Text] [Related]
10. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
11. Recent progress on the role of ChREBP in glucose and lipid metabolism.
Iizuka K
Endocr J; 2013; 60(5):543-55. PubMed ID: 23604004
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
13. [The transcription factor ChREBP: a key modulator of insulin sensitivity?].
Benhamed F; Poupeau A; Postic C
Med Sci (Paris); 2013; 29(8-9):765-71. PubMed ID: 24005632
[TBL] [Abstract][Full Text] [Related]
14. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
Takahashi N; Qi Y; Patel HR; Ahima RS
J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription.
Ishii S; Iizuka K; Miller BC; Uyeda K
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15597-602. PubMed ID: 15496471
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate responsive element binding protein and lipid homeostasis.
Denechaud PD; Girard J; Postic C
Curr Opin Lipidol; 2008 Jun; 19(3):301-6. PubMed ID: 18460923
[TBL] [Abstract][Full Text] [Related]
17. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M
Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235
[TBL] [Abstract][Full Text] [Related]
18. Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling.
Liu W; Cao H; Ye C; Chang C; Lu M; Jing Y; Zhang D; Yao X; Duan Z; Xia H; Wang YC; Jiang J; Liu MF; Yan J; Ying H
Nat Commun; 2014 Dec; 5():5684. PubMed ID: 25471065
[TBL] [Abstract][Full Text] [Related]
19. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of carbohydrate metabolism by insulin: role of transcription factor SREBP-1c in the hepatic transcriptional effects of the hormone].
Foufelle F; Ferré P
J Soc Biol; 2001; 195(3):243-8. PubMed ID: 11833461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
